SUNRISE, Fla., Feb. 3, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc., (Nasdaq:BHRT) today announced it has arranged with its local partner, Biomedica, in Italy, for a complete grant-supported study of the Bioheart A&C Bio Science T-PLS(r) Twin-Pulsatile Life Support System, a blood pump that is introduced through small percutaneous punctures into the femoral artery and femoral vein of a patient. The first shipments were made this week to a hospital in Italy, and testing on the system should be completed within 45 days. If the test results are positive, sales forecast for the systems in Italy alone for 2009 will be approximately 35 units at $60,000 each, for a total contract value estimated at $2,100,000.
